Kenneth Londoner
Chief Executive Officer at NeuroClear Technologies, Inc.
Net worth: 180 236 $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jerome Zeldis | M | 74 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT.
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 11 years |
Jeffrey O'Donnell | M | 64 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT.
NeuroClear Technologies, Inc.
NeuroClear Technologies, Inc. Medical SpecialtiesHealth Technology NeuroClear Technologies, Inc. engages in the development of medical technology solutions. It focuses on electroneurogram recordings. The company is headquartered in Westport, CT. | 11 years |
Frederick Hrkac | M | 58 | 2 years | |
Natasha Drapeau | F | - |
NeuroClear Technologies, Inc.
NeuroClear Technologies, Inc. Medical SpecialtiesHealth Technology NeuroClear Technologies, Inc. engages in the development of medical technology solutions. It focuses on electroneurogram recordings. The company is headquartered in Westport, CT.
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 6 years |
Samuel Navarro | M | 68 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 4 years |
Lucy M. Duncan-Scheman | F | - |
Safe-Ports Holdings LLC
Safe-Ports Holdings LLC MiscellaneousMiscellaneous Safe-Ports Holdings, LLC operates as a holding company with interests in shipping and shipping port companies. The company was founded by Kenneth L. Londoner in July 2005 and is headquartered in Columbia, SC. | - |
Anthony Zook | M | 63 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 4 years |
Lora Mikolaitis | F | 51 | 15 years | |
Zachary Koch | M | - | 2 years | |
Budimir S. Drakulic | M | 74 | 15 years | |
Jess Emery Jones | M | 45 | 16 years | |
Nicholas U. Spring | M | - |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | - |
Steven King | M | - |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | - |
Andrew Gornell Ballou | M | - | 5 years | |
Michael Dougherty | M | 66 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 4 years |
Brenda Castrodad | F | - | 3 years | |
Dennis Purcell | M | 68 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 4 years |
Seymour Jones | M | 92 |
The Leonard N Stern School of Business
| 31 years |
Katie Freshwater | F | - | 2 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Steven Chaussy | M | 70 |
Viralclear Pharmaceuticals, Inc.
Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | 12 years |
Steven C. Berger | M | 63 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 3 years |
Brian Posner | M | 62 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 5 years |
Kevin T. Dunphy | M | 75 |
Aduromed Industries, Inc.
| 4 years |
David Ian Johnson | M | 66 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | - |
Vincent W. Renz | M | 67 | 4 years | |
Patrick J. Maguire | M | 71 | 4 years | |
David J. Drachman | M | 66 | - | |
Greg Cash | M | 66 | 3 years | |
Richard Rosenblum | M | 65 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 6 years |
Andrew Filler | M | 56 | 4 years | |
Philip Friedman | M | 50 | - | |
Roy Tanaka | M | 75 | 7 years | |
Glenn Perillo | M | - |
The Leonard N Stern School of Business
| 5 years |
Patrick Gallagher | M | 59 | 10 years | |
Mike M. Goldberg | M | 65 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 1 years |
James Sapirstein | M | 63 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 2 years |
Kalyanam Shivkumar | M | 56 | 2 years | |
William Uglow | M | 76 | - | |
Jonathan Steinhouse | M | 57 | - | |
James A. Heisch | M | 80 | 3 years | |
James Barry | M | 64 | 3 years | |
Donald Foley | M | 73 | 9 years | |
Damien R. Tanaka | M | 80 |
Aduromed Industries, Inc.
| 6 years |
Tiffini Wittwer | F | - | - | |
Martha Pease | F | 66 | 2 years | |
Gregory David Sadowski | M | 51 | - | |
Asher Holzer | M | 74 | - | |
Michael E. Hanson | M | 74 | - | |
Richard Brounstein | M | 74 | 4 years | |
David Weild | M | 67 | 9 years | |
Gregory Scott Steier | M | - |
The Leonard N Stern School of Business
| 7 years |
James Klein | M | 59 | 2 years | |
Nachum Stein | M | 75 |
Alliqua BioMedical, Inc.
Alliqua BioMedical, Inc. BiotechnologyHealth Technology Alliqua BioMedical, Inc. engages in commercializing differentiated regenerative medical products which assist the body in the repair or replacement of soft tissue. Its commercial wound care portfolio consists of wound bed preparation and human biologics. It also manufactures custom electron beam cross-linked and aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was founded on October 27, 1997 and is headquartered in Langhorne, PA. | 1 years |
Mark Kroll | M | 71 | 4 years | |
Boris Groysberg | M | 52 |
The Leonard N Stern School of Business
| 4 years |
Jeffrey Lipson | M | 56 |
The Leonard N Stern School of Business
| 2 years |
Adam Marc Bench | M | - |
The Leonard N Stern School of Business
| 2 years |
Steve Mermelstein | M | - |
The Leonard N Stern School of Business
| 2 years |
Paul Vassilakos | M | 46 |
The Leonard N Stern School of Business
| 4 years |
William Wright | M | - |
The Leonard N Stern School of Business
| 4 years |
Maria Giovanna Calloni | F | 59 |
The Leonard N Stern School of Business
| 2 years |
Terrence Purcell | M | - |
The Leonard N Stern School of Business
| 2 years |
Jackson Dunckel | M | 60 |
The Leonard N Stern School of Business
| 2 years |
Jim Johnson | M | - |
The Leonard N Stern School of Business
| 4 years |
Scott Romanoff | M | - |
The Leonard N Stern School of Business
| 4 years |
Andrew M. Silberstein | M | 56 |
The Leonard N Stern School of Business
| 2 years |
Keith Anthony Dubauskas | M | - |
The Leonard N Stern School of Business
| 5 years |
Amit Sinha | M | - |
The Leonard N Stern School of Business
| 2 years |
Gary Survis | M | - |
The Leonard N Stern School of Business
| 3 years |
Nanette Aguirre | F | - |
The Leonard N Stern School of Business
| 4 years |
Jack Mui | M | - |
The Leonard N Stern School of Business
| 4 years |
Fabrizio Arengi Bentivoglio | M | 60 |
The Leonard N Stern School of Business
| 5 years |
Dariusz Robert Gorka | M | 58 |
The Leonard N Stern School of Business
| 2 years |
Edward Siegel | M | - |
The Leonard N Stern School of Business
| 2 years |
John Orwin | M | 59 |
The Leonard N Stern School of Business
| 2 years |
Bradley Ball | M | - |
The Leonard N Stern School of Business
| 2 years |
Justin Pollack | M | - |
The Leonard N Stern School of Business
| 4 years |
Nitin P. Karnani | M | - |
The Leonard N Stern School of Business
| 4 years |
Dave Daglio | M | - |
The Leonard N Stern School of Business
| 2 years |
Ashim Mehra | M | - |
The Leonard N Stern School of Business
| 2 years |
James LaChance | M | 59 |
The Leonard N Stern School of Business
| 2 years |
Eric Wolford | M | 57 |
The Leonard N Stern School of Business
| 2 years |
Herbert Cunitz | M | 61 |
The Leonard N Stern School of Business
| 2 years |
Scott D. Steele | M | - |
The Leonard N Stern School of Business
| 2 years |
Brian DiDonato | M | 57 |
The Leonard N Stern School of Business
| 2 years |
Eric Brachfeld | M | - |
The Leonard N Stern School of Business
| 2 years |
Gao Bin | M | 61 |
The Leonard N Stern School of Business
| 3 years |
Stacey M. Lituchy | F | - |
The Leonard N Stern School of Business
| 3 years |
Marc Estigarribia | M | 63 |
The Leonard N Stern School of Business
| 2 years |
Matty Yohannan | M | - |
The Leonard N Stern School of Business
| 4 years |
Joseph R. Taylor | M | - |
The Leonard N Stern School of Business
| 3 years |
David Leong | M | - |
The Leonard N Stern School of Business
| 4 years |
Humberto Zesati | M | 57 |
The Leonard N Stern School of Business
| 2 years |
Richard L. Wolfe | M | - |
Aduromed Industries, Inc.
| - |
Peter A. Schwartzman | M | - |
The Leonard N Stern School of Business
| 4 years |
Manfred Knof | M | 58 |
The Leonard N Stern School of Business
| 2 years |
Matt Maslow | M | - |
The Leonard N Stern School of Business
| 3 years |
Mark Morgan | M | - |
The Leonard N Stern School of Business
| 3 years |
Otto Chan | M | - |
The Leonard N Stern School of Business
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 99 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Kenneth Londoner
- Personal Network